Jing An

Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias

Zhihong Zeng, Ismael Samudio, Mark F. Munsell et al. · Molecular Cancer Therapeutics · 2006 · 186 citations

Medicine, Oncology, Pharmacology +17

Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from Chemokines

Naiming Zhou, Zhaowen Luo, Jiansong Luo et al. · Journal of Biological Chemistry · 2002 · 117 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Distinct Functional Sites for Human Immunodeficiency Virus Type 1 and Stromal Cell-Derived Factor 1α on CXCR4 Transmembrane Helical Domains

Shaomin Tian, Won-Tak Choi, Dongxiang Liu et al. · Journal of Virology · 2005 · 73 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors

Won‐Tak Choi, Shaomin Tian, Chang‐Zhi Dong et al. · Journal of Virology · 2005 · 71 citations · Full text

Life Sciences, Chemical Biology, Molecular Biology +17

Development of a Novel Class of Tubulin Inhibitors with Promising Anticancer Activities

Jingle Xi, Xuejun Zhu, Yongmei Feng et al. · Molecular Cancer Research · 2013 · 41 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17